These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38260287)

  • 1. Innate Immune Activation and Mitochondrial ROS Invoke Persistent Cardiac Conduction System Dysfunction after COVID-19.
    Ashok D; Liu T; Criscione J; Prakash M; Kim B; Chow J; Craney M; Papanicolaou KN; Sidor A; Brian Foster D; Pekosz A; Villano J; Kim DH; O'Rourke B
    bioRxiv; 2024 Jan; ():. PubMed ID: 38260287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human iPSC-Derived Cardiomyocytes Are Susceptible to SARS-CoV-2 Infection.
    Sharma A; Garcia G; Wang Y; Plummer JT; Morizono K; Arumugaswami V; Svendsen CN
    Cell Rep Med; 2020 Jul; 1(4):100052. PubMed ID: 32835305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Disrupts Proximal Elements in the JAK-STAT Pathway.
    Chen DY; Khan N; Close BJ; Goel RK; Blum B; Tavares AH; Kenney D; Conway HL; Ewoldt JK; Chitalia VC; Crossland NA; Chen CS; Kotton DN; Baker SC; Fuchs SY; Connor JH; Douam F; Emili A; Saeed M
    J Virol; 2021 Sep; 95(19):e0086221. PubMed ID: 34260266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network pharmacology and RNA-sequencing reveal the molecular mechanism of Xuebijing injection on COVID-19-induced cardiac dysfunction.
    He DD; Zhang XK; Zhu XY; Huang FF; Wang Z; Tu JC
    Comput Biol Med; 2021 Apr; 131():104293. PubMed ID: 33662681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy.
    Eskandarian Boroujeni M; Sekrecka A; Antonczyk A; Hassani S; Sekrecki M; Nowicka H; Lopacinska N; Olya A; Kluzek K; Wesoly J; Bluyssen HAR
    Front Immunol; 2022; 13():888897. PubMed ID: 35663932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human iPSC-Derived Cardiomyocytes are Susceptible to SARS-CoV-2 Infection.
    Sharma A; Garcia G; Arumugaswami V; Svendsen CN
    bioRxiv; 2020 Apr; ():. PubMed ID: 32511402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Infected Cardiomyocytes Recruit Monocytes by Secreting CCL2.
    Chen S; Yang L; Nilsson-Payant B; Han Y; Jaffré F; Zhu J; Wang P; Zhang T; Redmond D; Houghton S; Møller R; Hoagland D; Horiuchi S; Acklin J; Lim J; Bram Y; Richardson C; Chandar V; Borczuk A; Huang Y; Xiang J; Ho D; Schwartz R; tenOever B; Evans T
    Res Sq; 2020 Nov; ():. PubMed ID: 33236003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 spike protein-mediated cardiomyocyte fusion may contribute to increased arrhythmic risk in COVID-19.
    Clemens DJ; Ye D; Zhou W; Kim CSJ; Pease DR; Navaratnarajah CK; Barkhymer A; Tester DJ; Nelson TJ; Cattaneo R; Schneider JW; Ackerman MJ
    PLoS One; 2023; 18(3):e0282151. PubMed ID: 36888581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of sarcomeric proteins via upregulation of JAK/STAT signaling underlies interferon-γ-induced contractile deficit in engineered human myocardium.
    Zhan RZ; Rao L; Chen Z; Strash N; Bursac N
    Acta Biomater; 2021 May; 126():144-153. PubMed ID: 33705988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR2 Signaling Restricts SARS-CoV-2 Infection.
    Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
    mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-Specific Mechanisms in the Heart of COVID-19 Patients.
    Tsai EJ; Cˇiháková D; Tucker NR
    Circ Res; 2023 May; 132(10):1290-1301. PubMed ID: 37167361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
    Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
    Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac SARS-CoV-2 infection is associated with pro-inflammatory transcriptomic alterations within the heart.
    Bräuninger H; Stoffers B; Fitzek ADE; Meißner K; Aleshcheva G; Schweizer M; Weimann J; Rotter B; Warnke S; Edler C; Braun F; Roedl K; Scherschel K; Escher F; Kluge S; Huber TB; Ondruschka B; Schultheiss HP; Kirchhof P; Blankenberg S; Püschel K; Westermann D; Lindner D
    Cardiovasc Res; 2022 Jan; 118(2):542-555. PubMed ID: 34647998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diminished antiviral innate immune gene expression in the placenta following a maternal SARS-CoV-2 infection.
    Coler B; Wu TY; Carlson L; Burd N; Munson J; Dacanay M; Cervantes O; Esplin S; Kapur RP; Feltovich H; Adams Waldorf KM
    Am J Obstet Gynecol; 2023 Apr; 228(4):463.e1-463.e20. PubMed ID: 36126729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N7-Methylation of the Coronavirus RNA Cap Is Required for Maximal Virulence by Preventing Innate Immune Recognition.
    Pan R; Kindler E; Cao L; Zhou Y; Zhang Z; Liu Q; Ebert N; Züst R; Sun Y; Gorbalenya AE; Perlman S; Thiel V; Chen Y; Guo D
    mBio; 2022 Feb; 13(1):e0366221. PubMed ID: 35073761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrioventricular and Sinus Node Dysfunction in Stable COVID-19 Patients.
    Babapoor-Farrokhran S; Batnyam U; Wiener PC; Kanjanahattakij N; Khraisha O; Amanullah A; Mainigi SK
    SN Compr Clin Med; 2020; 2(11):1955-1958. PubMed ID: 32901230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes.
    Bojkova D; Wagner JUG; Shumliakivska M; Aslan GS; Saleem U; Hansen A; Luxán G; Günther S; Pham MD; Krishnan J; Harter PN; Ermel UH; Frangakis AS; Milting H; Zeiher AM; Klingel K; Cinatl J; Dendorfer A; Eschenhagen T; Tschöpe C; Ciesek S; Dimmeler S
    Cardiovasc Res; 2020 Dec; 116(14):2207-2215. PubMed ID: 32966582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial derived cells and cardiomyocytes.
    Li Y; Renner DM; Comar CE; Whelan JN; Reyes HM; Cardenas-Diaz FL; Truitt R; Tan LH; Dong B; Alysandratos KD; Huang J; Palmer JN; Adappa ND; Kohanski MA; Kotton DN; Silverman RH; Yang W; Morrisey E; Cohen NA; Weiss SR
    bioRxiv; 2020 Nov; ():. PubMed ID: 32995797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular mechanism of cardiac injury in SARS-CoV-2 infection: Focus on mitochondrial dysfunction.
    Shen Y; Chen M; Gu W; Wan J; Cheng Z; Shen K; Zhang W; He J; Wang Y; Deng X
    J Infect Public Health; 2023 May; 16(5):746-753. PubMed ID: 36958170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All hands on deck: SARS-CoV-2 proteins that block early anti-viral interferon responses.
    Setaro AC; Gaglia MM
    Curr Res Virol Sci; 2021; 2():100015. PubMed ID: 34786565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.